Skip to main content
Equibles

Polar Capital Holdings Plc

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1837309 London, X0
Back to MDGL Full portfolio

Position in MDGL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$131,162,924
-$20,282,181 QoQ
Shares Held
244,274
-15.6% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MDGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Polar Capital Holdings Plc holds $3,774,805,029 across 41 Biotechnology names. MDGL ranks #9 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELVN
Enliven Therapeutics, Inc.
 6,430,636 $326,354,777
2 XENE
Xenon Pharmaceuticals Inc.
 4,570,556 $275,878,760
3 CYTK
Cytokinetics Inc
 2,253,649 $191,988,358
4 RYTM
Rhythm Pharmaceuticals, Inc.
 1,663,632 $184,713,060
5 ARQT
Arcutis Biotherapeutics, Inc.
 6,606,945 $173,234,097
6 ASND
Ascendis Pharma A/S
 616,908 $164,541,701
7 BBIO
BridgeBio Pharma, Inc.
 2,063,609 $153,697,598
8 ALNY
Alnylam Pharmaceuticals, Inc.
 482,751 $145,322,533

All Filings in MDGL

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $131,162,924 244,274
2026-03-31 $151,445,105 289,310
2025-12-31 $157,319,733 270,151
2025-09-30 $121,615,533 265,154
2025-06-30 $68,218,082 225,410
2025-03-31 $49,757,370 150,220
2024-12-31 $42,496,260 137,720
2024-09-30 $21,322,804 100,475
2024-06-30 $35,104,048 125,300
2024-03-31 $33,434,743 125,205